TY  - JOUR
AU  - Iborra, Marisa
AU  - Gisbert, Javier P
AU  - Bosca-Watts, Marta Maia
AU  - Lopez-Garcia, Alicia
AU  - Garcia-Sanchez, Valle
AU  - Lopez-Sanroman, Antonio
AU  - Hinojosa, Esther
AU  - Marquez, Lucia
AU  - Garcia-Lopez, Santiago
AU  - Chaparro, Maria
AU  - Aceituno, Montserrat
AU  - Calafat, Margalida
AU  - Guardiola, Jordi
AU  - Belloc, Blanca
AU  - Ber, Yolanda
AU  - Bujanda, Luis
AU  - Beltran, Belen
AU  - Rodriguez-Gutierrez, Cristina
AU  - Barrio, Jesus
AU  - Cabriada, Jose Luis
AU  - Rivero, Montserrat
AU  - Camargo, Raquel
AU  - van Domselaar, Manuel
AU  - Villoria, Albert
AU  - Schuterman, Hugo Salata
AU  - Hervas, David
AU  - Nos, Pilar
PY  - 2016
DO  - 10.1007/s00535-016-1274-1
UR  - http://hdl.handle.net/10668/10635
T2  - Journal of gastroenterology
AB  - Background Ulcerative colitis (UC) treatment is focused to achieve mucosal healing, avoiding disease progression. The study aimed to evaluate the real-world effectiveness of adalimumab (ADA) in UC and to identify predictors ofremission to ADA. Methods...
LA  - en
PB  - Springer
KW  - Adalimumab
KW  - Ulcerative colitis
KW  - Treatment
TI  - Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.
TY  - research article
VL  - 52
ER  -